Home | Publications | Free Reports place holder

Free Reports


South Africa Striving for Success: Developments in the pharmaceuticals sector

Publication Date June 2006

Summary

South Africa Striving for Success: Developments in the pharmaceuticals sector, written by Chiltern International, provides an overview of the development of the pharmaceutical research and development (R&D) sector in South Africa.

Format of paper:
• Healthcare ambiguity
• International attention
• Stimulating Domestic R&D
• Healthcare controversy
• Regional pioneer
• References

The paper is only available from Piribo as a free download.
view this report …

Patient recruitment for clinical trials: Encouraging positive outcomes

Publication Date December 2005

Summary

Patient recruitment for clinical trials: Encouraging positive outcomes, written by Chiltern International, outlines the key factors in running a successful recruitment programme for clinical trials.

As the costs of clinical development are rising rapidly in relation to the other parts of the R&D process it is essential that the recruitment process be as efficient as possible. “A degree of realism is required in order to optimise subject recruitment for clinical trials. Although there is always a time and cost pressure, any difficulties for a clinical project could actually be exacerbated if subject recruitment rates are approached in an unrealistic manner”, says the paper.

The paper makes a number of recommendations and pointers relevant for all those with an interest in clinical trials. These include:

  • As clinical trials have become larger they have also become more global. The internationalisation of clinical research is also important for companies in order to give local physicians experience of working with a new product

  • When conducting patient studies, it is important to be as proactive as possible to identify sites that will be efficient at recruiting

  • As a whole the pharmaceutical industry could be helped in terms of patient recruitment for trials if the public better understood the value of clinical trials and their role in the development of new medicines.

    Format of paper:
    • Drug development
    • Rising clinical expense
    • Patient recruitment matters
    • Patient recruitment strategy
    • Global recruitment
    • The ethical angle
    • Encouraging patient participation
    The paper is only available from Piribo as a free download.

    view this report …


    Survey of Life Sciences Websites

    Publication Date June 2005

    Summary

    The survey by net-progress examines three key areas of performance, namely website quality, website presence and website accessibility.

    The findings of this survey show that websites in the Life Sciences sector perform fairly well. Website quality in this sector is above average. This should mean that on a majority of websites examined, visitors should find that there are few problems that prevent them from carrying out the tasks they set out to complete. Website presence is fairly typical of most sectors. All the websites examined did well for the company names, and a majority did well for product names in the search engines. Performance was predictably more varied for generic search terms. The average number of links to the websites were also high, but the range reflected that some companies have work to do in this aspect of website presence.

    The one area that almost all of the websites examined have much scope for improvement is that of accessibility. Only one of the websites tested passed the World Wide Web Consortium’s Website and Content Accessibility Guideline Priority 1 checkpoints - the minimum recommended level of accessibility.

    GlaxoSmithKline were given the net-progress Gold Standard Award for their website performance. AstraZeneca were commended for both website presence and website quality.

    Covers the following companies:
    Acambis, Alizyme, Ark Therapeutics, AstraZeneca, Axis Shield Cambridge Antibody, Dechra, Goldshiled, GSK, Marshall Edwards, Oxford Biomedica, Phytopharm, Protherics, Sector Average, Shire, Skye Pharma, Vernalis

    view this free report …


    UK Pharmaceutical Executive Pay - Free Summary

    Publication Date March 2005

    Summary

    UK Pharmaceutical Executive Pay - Insight into Director Remuneration represents an effort to understand the pay of executive directors and non-executive directors working in the top 40 UK public biotechnology, healthcare and pharmaceutical companies.

    view this report …


    The Pharma e-50

    Publication Date 2001

    Summary

    A study of the 50 largest pharmaceutical companies and their use of the Internet to reach their markets

    view this report …

    		•